Floatz logo

CARVEDILOL

Portal Hypertension

West China HospitalSmall moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
68/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Portal Hypertension cohort.

Asset / SponsorPhaseRating
SIMVASTATIN
Kafrelsheikh University
Phase 4BBB
PROPRANOLOL
West China Hospital
Phase 4BBB
Apixaban
Asian Institute Of Medical Sciences
Phase 4BB
Dipyridamole
Northern Jiangsu People's Hospital
Phase 4BB
Acetylsalicylic Acid
Northern Jiangsu People's Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

CARVEDILOL is also rated in:

esophageal varicesDormant
BBB
Indicative ·
73 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
72 / 100
View asset →
cardiomyopathyDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →